Skip to main content
. 2014 Summer;5(3):137–142.

Table 1.

The characteristics of the type 2 diabetic patients with respect to seropositivity for Helicobacter pylori

Parameter HP - , n=72 (34.1%) HP + , n=139 (65.9%) P value
Gender (Female/Male) 47(65.3%)/25 (34.7%) 88 (63.3%)/51 (36.7%) 0.778
Diabetes duration (year) 7.4±5.4 7.4±5.5 0.971
Insulin Resistance risk factors

  • Age (year)

 51.5±8.3 53.5±9.0 0.128

  • BMI

 29.4±4.9 28.8±4.8 0.427

  • Waist circumference (cm)

 101.46±12.31 100.69±10.82 0.971

  • Family history of diabetes (+/-)

 53 (73.6%) /19 (26.4%) 103 (75.0%) / 36 (26.0%) 0.825

  • Hypertension (+/-)

 32 (44.4%)/40 (55.6%) 64 (46.0%)/75 (54.0%) 0.825

  • Exercise degree

 0.478

  • >150 min per week

 2 (2.9%) 11 (7.9%)

  • 30-150 min per week

 4 (5.7%) 10 (7.2%)

  • <30 min per week

 15 (21.4%) 26 (18.7%)

  • No

 51 (72.9%) 92 (66.2%)
Diabetes Complications

  • Neuropathy

 0.165

  • Motor

 2 (2.8%) 3 (2.2%)

  • Sensory

 31 (43.1%) 79 (56.8%)

  • No

 39 (54.1%) 57 (41%)

  • Autonomous neuropathy (+/-)

 44 (61.1%)/28 (38.9%) 74 (53.2%)/65 (46.8%) 0.275

  • Gastroparesia (+/-)

 16 (22.2%)/56 (77.8%) 34 (24.5%)/105 (75.5%) 0.717

  • Nephropathy

0.795

  • Macroalbuminuria

 5 (6.9%) 13 (9.4%)

  • Microalbuminuria

 19 (26.4%) 33 (23.7%)

  • No

 48 (66.7%) 93 (66.9%)

  • CAD (+/-)

 16 (22.2%)/56 (77.8%) 38 (27.3%)/101 (72.7%) 0.419

  • PAD (+/-)

 17 (23.6%)/55 (76.4%) 22 (15.8%)/117 (84.2%) 0.167

  • CVA (+/-)

 6 (8.3%)/66 (91.7%) 14 (10.1%)/125 (89.9%) 0.683

  • Retinopathy

 0.664

  • Proliferative

 5 (6.9%) 6 (4.3%)

  • Non-proliferative

 22 (30.6%) 40 (28.8%)

  • No

 45 (62.5%) 93 (66.9%)

  • Cataract (+/-)

 31 (43.1%)/41 (56.9%) 42 (30.7%)/95 (69.3%) 0.074

  • Dental diseases (+/-)

 6 (8.3%)/66 (91.7%) 16 (11.7%)/121 (88.3%) 0.454
Lipid profile

  • HDL (mg/dL)

 69.2±29.2 60.7±26.7 0.037

  • LDL (mg/dL)

 107.1±43.2 116.0±51.7 0.212

  • TG (mg/dL)

 224.2±100.2 229.3±114.6 0.747

  • Cholesterol (mg/dL)

 205.1±63.2 207.3±67.4 0.820